Verily

Compensation and perks used to be good. They are still decent, but not at the level of others in Alphabet.

Some smart engineers and scientists still remain.

Some links to the Google software infrastructure and training represent good growth opportunities for those for whom the potential skill set is useful.

Management is a complete fiasco, with limited responsibility for decisions and product vision.

Consistent blame is given to junior team members who were often not even aware of a specific decision until they are blamed.

There is an obsession with chasing short-term profits (e.g., C19) over fixing technical debt and supporting long-term products to help differentiate the company from other health technology start-ups.

Well-documented issues, such as those articulated in Business Insider and Science press, exist. For the latter, the CEO suggested that Verily's medical products do not require in-vivo testing, which is utterly laughable.

There is an inability to accept that any outcome is not extremely good, and pressure on junior ICs to not present any item that may suggest a product is not perfect, leading to the inability to build distinct, useful products for their customers.

A bizarre focus on a partnership model is often sold to partners on immature products, which are often under-supported and poorly delivered.

Promotion opportunities are extremely limited.

Despite underlying Google infrastructure, somehow the faculties, strategy, legal, and HR are all under-supported and overworked.

A complete rebuild is required. Some is occurring, and the new C-suite hires are clearly trying to turn the ship around, likely too late for huge proportions of the company.